BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25800227)

  • 1. Synthetic artificial microRNAs targeting UCA1-MALAT1 or c-Myc inhibit malignant phenotypes of bladder cancer cells T24 and 5637.
    Fu X; Liu Y; Zhuang C; Liu L; Cai Z; Huang W
    Mol Biosyst; 2015 May; 11(5):1285-9. PubMed ID: 25800227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic Tet-inducible artificial microRNAs targeting β-catenin or HIF-1α inhibit malignant phenotypes of bladder cancer cells T24 and 5637.
    Zhan Y; Liu Y; Lin J; Fu X; Zhuang C; Liu L; Xu W; Li J; Chen M; Zhao G; Huang W; Cai Z
    Sci Rep; 2015 Nov; 5():16177. PubMed ID: 26541358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic artificial "long non-coding RNAs" targeting oncogenic microRNAs and transcriptional factors inhibit malignant phenotypes of bladder cancer cells.
    Xie H; Zhan H; Gao Q; Li J; Zhou Q; Chen Z; Liu Y; Ding M; Xiao H; Liu Y; Huang W; Cai Z
    Cancer Lett; 2018 May; 422():94-106. PubMed ID: 29501702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Synthetic Light-switchable System based on CRISPR Cas13a Regulates the Expression of LncRNA MALAT1 and Affects the Malignant Phenotype of Bladder Cancer Cells.
    Qi F; Tan B; Ma F; Zhu B; Zhang L; Liu X; Li H; Yang J; Cheng B
    Int J Biol Sci; 2019; 15(8):1630-1636. PubMed ID: 31360106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder.
    Han Y; Liu Y; Nie L; Gui Y; Cai Z
    Urology; 2013 Jan; 81(1):209.e1-7. PubMed ID: 23153939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer.
    Chen M; Zhuang C; Liu Y; Li J; Dai F; Xia M; Zhan Y; Lin J; Chen Z; He A; Xu W; Zhao G; Guo Y; Cai Z; Huang W
    Cancer Lett; 2016 Jun; 376(1):155-64. PubMed ID: 27018306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1.
    Han Y; Liu Y; Zhang H; Wang T; Diao R; Jiang Z; Gui Y; Cai Z
    FEBS Lett; 2013 Nov; 587(23):3875-82. PubMed ID: 24396870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic Tet-inducible small hairpin RNAs targeting hTERT or Bcl-2 inhibit malignant phenotypes of bladder cancer T24 and 5637 cells.
    Lin J; Liu Y; Zhan Y; Zhuang C; Liu L; Fu X; Xu W; Li J; Chen M; Cai Z; Huang W
    Tumour Biol; 2016 Mar; 37(3):3115-21. PubMed ID: 26427661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA‑335 inhibits bladder cancer cell growth and migration by targeting mitogen‑activated protein kinase 1.
    Wang X; Wu G; Cao G; Chen X; Huang J; Jiang X; Hou J
    Mol Med Rep; 2016 Aug; 14(2):1765-70. PubMed ID: 27356628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of long non-coding RNA UCA1 by CRISPR/Cas9 attenuated malignant phenotypes of bladder cancer.
    Zhen S; Hua L; Liu YH; Sun XM; Jiang MM; Chen W; Zhao L; Li X
    Oncotarget; 2017 Feb; 8(6):9634-9646. PubMed ID: 28038452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic Bax-Anti Bcl2 combination module actuated by super artificial hTERT promoter selectively inhibits malignant phenotypes of bladder cancer.
    Liu L; Liu Y; Zhang T; Wu H; Lin M; Wang C; Zhan Y; Zhou Q; Qiao B; Sun X; Zhang Q; Guo X; Zhao G; Zhang W; Huang W
    J Exp Clin Cancer Res; 2016 Jan; 35():3. PubMed ID: 26743236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling of microRNAs associated with UCA1 in bladder cancer cells.
    Xie X; Pan J; Wei L; Wu S; Hou H; Li X; Chen W
    Int J Oncol; 2016 Apr; 48(4):1617-27. PubMed ID: 26820254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic regulatory RNAs selectively suppress the progression of bladder cancer.
    Zhuang C; Huang X; Zhuang C; Luo X; Zhang X; Cai Z; Gui Y
    J Exp Clin Cancer Res; 2017 Oct; 36(1):151. PubMed ID: 29084575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer.
    He A; Liu Y; Chen Z; Li J; Chen M; Liu L; Liao X; Lv Z; Zhan Y; Zhuang C; Lin J; Huang W; Mei H
    J Exp Clin Cancer Res; 2016 Aug; 35(1):125. PubMed ID: 27514530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic miRNA sponges driven by mutant hTERT promoter selectively inhibit the progression of bladder cancer.
    Zhuang CL; Fu X; Liu L; Liu YC; Huang WR; Cai ZM
    Tumour Biol; 2015 Jul; 36(7):5157-63. PubMed ID: 25775949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-101 suppresses motility of bladder cancer cells by targeting c-Met.
    Hu Z; Lin Y; Chen H; Mao Y; Wu J; Zhu Y; Xu X; Xu X; Li S; Zheng X; Xie L
    Biochem Biophys Res Commun; 2013 May; 435(1):82-7. PubMed ID: 23618864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting malignant phenotypes of the bladder cancer cells by silencing long noncoding RNA SChLAP1.
    Zhang J; Shi Z; Nan Y; Li M
    Int Urol Nephrol; 2016 May; 48(5):711-6. PubMed ID: 26861061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircCDYL inhibits the expression of C-MYC to suppress cell growth and migration in bladder cancer.
    Sun J; Zhang H; Tao D; Xie F; Liu F; Gu C; Wang M; Wang L; Jiang G; Wang Z; Xiao X
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1349-1356. PubMed ID: 30968727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol induces apoptosis of bladder cancer cells via miR‑21 regulation of the Akt/Bcl‑2 signaling pathway.
    Zhou C; Ding J; Wu Y
    Mol Med Rep; 2014 Apr; 9(4):1467-73. PubMed ID: 24535223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells.
    Liu Y; Han Y; Zhang H; Nie L; Jiang Z; Fa P; Gui Y; Cai Z
    PLoS One; 2012; 7(12):e52280. PubMed ID: 23284967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.